Tubal contraception and ovarian cancer risk: a global view

Contraception. 2017 Mar;95(3):223-226. doi: 10.1016/j.contraception.2016.09.004. Epub 2016 Sep 9.

¹ Contraceptive Technology Innovation, FHI 360, 359 Blackwell St., Suite 200, Durham, NC 27701, USA. Electronic address: rcallahan@fhi360.org.
² Contraceptive Technology Innovation, FHI 360, 359 Blackwell St., Suite 200, Durham, NC 27701, USA.
³ Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
⁴ Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; Dept. of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115.

No abstract available

Publication types